Liver Diseases  >>  lopinavir/ritonavir  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lopinavir/ritonavir / Generic mfg.
NCT01153269: Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Completed
N/A
33
Europe
Lopinavir/Ritonavir (Kaletra)
Abbott
Human Immunodeficiency Virus-Infection
11/10
11/10
NCT00023218: Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Withdrawn
N/A
0
US
Lopinavir/Ritonavir, Efavirenz
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, Hepatitis C
 
 
NCT01614405: Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis

Completed
N/A
13
Canada
Truvada and Kaletra, Truvada, Tenofovir, Emtricitabine, Kaletra, lopinavir, ritonavir
University of Alberta, Abbott, Gilead Sciences, Canadian Institutes of Health Research (CIHR)
Primary Biliary Cirrhosis
07/15
08/15

Download Options